Id |
Subject |
Object |
Predicate |
Lexical cue |
T834 |
0-39 |
Sentence |
denotes |
White Matter/Oligodendroglial Pathology |
T835 |
40-91 |
Sentence |
denotes |
HIV can cause white matter damage (Gosztonyi et al. |
T836 |
92-113 |
Sentence |
denotes |
1994; Langford et al. |
T837 |
114-131 |
Sentence |
denotes |
2002; Xuan et al. |
T838 |
132-186 |
Sentence |
denotes |
2013) even with less severe forms of HAND (Chen et al. |
T839 |
187-205 |
Sentence |
denotes |
2009; Leite et al. |
T840 |
206-225 |
Sentence |
denotes |
2013; Correa et al. |
T841 |
226-232 |
Sentence |
denotes |
2015). |
T842 |
233-343 |
Sentence |
denotes |
Diffusion tensor magnetic resonance imaging (DTI) demonstrates white matter damage early in HAND (Ragin et al. |
T843 |
344-369 |
Sentence |
denotes |
2004; Stubbe-Drger et al. |
T844 |
370-388 |
Sentence |
denotes |
2012; Leite et al. |
T845 |
389-408 |
Sentence |
denotes |
2013; Correa et al. |
T846 |
409-415 |
Sentence |
denotes |
2015). |
T847 |
416-524 |
Sentence |
denotes |
White matter deficits are associated with cognitive impairment, including shortfalls in memory (Ragin et al. |
T848 |
525-565 |
Sentence |
denotes |
2005), executive function (Correa et al. |
T849 |
566-595 |
Sentence |
denotes |
2015), motor speed (Wu et al. |
T850 |
596-621 |
Sentence |
denotes |
2006; Stubbe-Drger et al. |
T851 |
622-682 |
Sentence |
denotes |
2012), and perhaps depression (Schmaal and van Velzen 2019). |
T852 |
683-785 |
Sentence |
denotes |
Preclinical studies in simian immunodeficiency virus- (SIV-) infected rhesus macaques (Marcario et al. |
T853 |
786-837 |
Sentence |
denotes |
2008) and HIV-infected humanized mice (Boska et al. |
T854 |
838-874 |
Sentence |
denotes |
2014) support the clinical findings. |
T855 |
875-967 |
Sentence |
denotes |
Injury to oligodendrocytes (OLs) can occur very early in the disease (see review, Liu et al. |
T856 |
968-975 |
Sentence |
denotes |
2016b). |
T857 |
976-1087 |
Sentence |
denotes |
Viral proteins, including Tat, gp120, and Nef, have been implicated in OL injury in vitro (Kimura-Kuroda et al. |
T858 |
1088-1109 |
Sentence |
denotes |
1994; Bernardo et al. |
T859 |
1110-1128 |
Sentence |
denotes |
1997; Radja et al. |
T860 |
1129-1150 |
Sentence |
denotes |
2003; Nukuzuma et al. |
T861 |
1151-1167 |
Sentence |
denotes |
2012; Zou et al. |
T862 |
1168-1217 |
Sentence |
denotes |
2015), and in animal models in vivo (Radja et al. |
T863 |
1218-1237 |
Sentence |
denotes |
2003; Hauser et al. |
T864 |
1238-1254 |
Sentence |
denotes |
2009; Zou et al. |
T865 |
1255-1261 |
Sentence |
denotes |
2015). |
T866 |
1262-1352 |
Sentence |
denotes |
Importantly, Tat has been detected in OLs in the brains of AIDS patients (Del Valle et al. |
T867 |
1353-1359 |
Sentence |
denotes |
2000). |
T868 |
1360-1424 |
Sentence |
denotes |
HIV likely damages OLs through both direct and indirect actions. |
T869 |
1425-1500 |
Sentence |
denotes |
OLs lack CD4, and reports of OL infection by HIV are variable (Esiri et al. |
T870 |
1501-1522 |
Sentence |
denotes |
1991; Albright et al. |
T871 |
1523-1549 |
Sentence |
denotes |
1996; Wohlschlaeger et al. |
T872 |
1550-1658 |
Sentence |
denotes |
2009); thus, HIV infection of OLs is unlikely a major avenue of OL or white matter damage (discussed below). |
T873 |
1659-1846 |
Sentence |
denotes |
Alternatively, bystander damage to OLs through the production of “virotoxins” and “cellular toxins” (Nath 1999) by infected neighboring cells is more likely to be operative (Hauser et al. |
T874 |
1847-1863 |
Sentence |
denotes |
2009; Zou et al. |
T875 |
1864-1883 |
Sentence |
denotes |
2015; Jensen et al. |
T876 |
1884-1900 |
Sentence |
denotes |
2019; Zou et al. |
T877 |
1901-1907 |
Sentence |
denotes |
2019). |
T878 |
1908-1962 |
Sentence |
denotes |
ARVs also contribute to OL cytotoxicity (Jensen et al. |
T879 |
1963-1981 |
Sentence |
denotes |
2015; Festa et al. |
T880 |
1982-2001 |
Sentence |
denotes |
2019; Jensen et al. |
T881 |
2002-2008 |
Sentence |
denotes |
2019). |
T882 |
2009-2200 |
Sentence |
denotes |
HIV-1 Tat directly induces damage in isolated OLs through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/N-methyl-D-aspartic acid (NMDA) receptor-dependent mechanisms (Zou et al. |
T883 |
2201-2270 |
Sentence |
denotes |
2015) and is also associated with abnormal Kv1.3 activity (Liu et al. |
T884 |
2271-2277 |
Sentence |
denotes |
2017). |
T885 |
2278-2374 |
Sentence |
denotes |
Immature OLs are preferentially targeted by Tat compared to differentiated OLs (Khurdayan et al. |
T886 |
2375-2392 |
Sentence |
denotes |
2004; Hahn et al. |
T887 |
2393-2409 |
Sentence |
denotes |
2012; Zou et al. |
T888 |
2410-2422 |
Sentence |
denotes |
2015, 2019). |
T889 |
2423-2671 |
Sentence |
denotes |
While the reasons why immature OLs are more susceptible to Tat are unclear, unlike mature OLs, Tat preferentially upregulates GSK-3β signaling in undifferentiated OLs by inhibiting Ca2+/calmodulin-dependent protein kinase II β (CaMKIIβ) (Zou et al. |
T890 |
2672-2678 |
Sentence |
denotes |
2019). |
T891 |
2679-2843 |
Sentence |
denotes |
Opioid abuse by itself can result in demyelination, leukoencephalopathy, and lesions in white matter (Offiah and Hall 2008; Eran and Barak 2009; Morales Odia et al. |
T892 |
2844-2861 |
Sentence |
denotes |
2010; Bora et al. |
T893 |
2862-2877 |
Sentence |
denotes |
2012; Li et al. |
T894 |
2878-2984 |
Sentence |
denotes |
2013), and the degree of myelin disruption correlates with the duration of opiate dependence (Ivers et al. |
T895 |
2985-2991 |
Sentence |
denotes |
2018). |
T896 |
2992-3209 |
Sentence |
denotes |
Chronic oxycodone exposure in rats causes some axonopathies and reduces the size of axonal fascicles, decreases myelin basic protein levels, and causes the accumulation of amyloid-β precursor protein (APP) (Fan et al. |
T897 |
3210-3216 |
Sentence |
denotes |
2018). |
T898 |
3217-3372 |
Sentence |
denotes |
Most preclinical studies have examined the effects of opioids and opioid receptor blockade on OL maturation and/or the timing of myelination (Hauser et al. |
T899 |
3373-3391 |
Sentence |
denotes |
1993; Knapp et al. |
T900 |
3392-3418 |
Sentence |
denotes |
1998; Stiene-Martin et al. |
T901 |
3419-3439 |
Sentence |
denotes |
2001; Sanchez et al. |
T902 |
3440-3458 |
Sentence |
denotes |
2008; Knapp et al. |
T903 |
3459-3486 |
Sentence |
denotes |
2009; Vestal-Laborde et al. |
T904 |
3487-3493 |
Sentence |
denotes |
2014). |
T905 |
3494-3572 |
Sentence |
denotes |
OLs can transiently express MORs and other opioid receptor types (Knapp et al. |
T906 |
3573-3597 |
Sentence |
denotes |
1998; Tryoen-Toth et al. |
T907 |
3598-3616 |
Sentence |
denotes |
2000; Knapp et al. |
T908 |
3617-3643 |
Sentence |
denotes |
2001; Stiene-Martin et al. |
T909 |
3644-3650 |
Sentence |
denotes |
2001). |
T910 |
3651-3778 |
Sentence |
denotes |
Selective MOR and possibly KOR activation can directly modulate the growth of OLs in vitro (Knapp and Hauser 1996; Knapp et al. |
T911 |
3779-3791 |
Sentence |
denotes |
1998, 2001). |
T912 |
3792-3911 |
Sentence |
denotes |
Despite long-standing evidence of white matter damage early during the infection even in asymptomatic PWH (Price et al. |
T913 |
3912-3929 |
Sentence |
denotes |
1988; Gray et al. |
T914 |
3930-3947 |
Sentence |
denotes |
1996; Chen et al. |
T915 |
3948-3973 |
Sentence |
denotes |
2009; Stubbe-Drger et al. |
T916 |
3974-3993 |
Sentence |
denotes |
2012; Jensen et al. |
T917 |
3994-4099 |
Sentence |
denotes |
2019), few studies have examined how opiate exposure affects OLs and myelin in neuroHIV (Tables 1 and 2). |
T918 |
4100-4245 |
Sentence |
denotes |
Increased demyelination is reported in SIV-infected rhesus macaques chronically treated with morphine (4× daily, up to 59 weeks) (Marcario et al. |
T919 |
4246-4252 |
Sentence |
denotes |
2008). |
T920 |
4253-4425 |
Sentence |
denotes |
Specifically, morphine-treated SIV macaques developed more subtle, focal, dysmyelinating lesions, with accumulations of macrophages in areas of myelin loss (Marcario et al. |
T921 |
4426-4481 |
Sentence |
denotes |
2008), as well as accompanying gliosis (Marcario et al. |
T922 |
4482-4507 |
Sentence |
denotes |
2008; Rivera-Amill et al. |
T923 |
4508-4529 |
Sentence |
denotes |
2010a; Bokhari et al. |
T924 |
4530-4536 |
Sentence |
denotes |
2011). |
T925 |
4537-4756 |
Sentence |
denotes |
Morphine exposure increased degeneration of OLs in Tat+ mice, which was accompanied by elevations in caspase-3 activation and TUNEL reactivity in OLs and reversible by naloxone or naltrexone, respectively (Hauser et al. |
T926 |
4757-4763 |
Sentence |
denotes |
2009). |
T927 |
4764-4827 |
Sentence |
denotes |
Although OLs can express MOR both in vivo (Stiene-Martin et al. |
T928 |
4828-4861 |
Sentence |
denotes |
2001) and in vitro (Hauser et al. |
T929 |
4862-4965 |
Sentence |
denotes |
2009), it remains unclear the extent to which MOR activation in OLs directly mediates HIV pathogenesis. |